Adoptive cell therapy (ACT) is a growing personalized immuno-oncology approach, delivered both in standard of care (SOC) and clinical trial (CT) settings.
Understanding patient and informal caregivers (ICs) experiences is crucial to optimizing care.
This qualitative systematic review explores the ACT experience across three elements: actors (patients and ICs), settings (CT and SOC), and phases of the care continuum.
